FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOURDON, E.
Right arrow Articles by BLACHE, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOURDON, E.
Right arrow Articles by BLACHE, D.
(The FASEB Journal. 1999;13:233-244.)
© 1999 FASEB


RESEARCH COMMUNICATION

Glucose and free radicals impair the antioxidant properties of serum albumin

EMMANUEL BOURDON, NADINE LOREAU and DENIS BLACHE 1

INSERM U498, Biochimie des Lipoprotéines et Interactions Vasculaires, Université de Bourgogne, Dijon, France


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Epidemiological data consistently show that reduced levels of serum albumin, which is the most abundant protein in plasma, are associated with an increased mortality risk. Various biological properties evidenced by direct effects of the albumin molecule may explain its beneficial effects. The present work aimed to investigate in vitro whether glycation or free radicals or both factors would affect the antioxidant properties of bovine serum albumin (BSA). Glycation was performed by long-term incubations (60 days) of BSA with increasing concentrations of glucose (up to 500 mmol/l) at 37°C. Minimally oxidized BSA was obtained after controlled incubations of dialyzed BSA samples with a water-soluble free radical generator [2,2' azo-bis(2-amidinopropane) HCl]. The glycation-mediated modifications and the free radical-induced conformational changes of BSA were monitored using intrinsic fluorescence measurements of the tryptophan residues and acrylamide as a quenching agent. Thiol groups, Amadori glycophore contents, and boronate binding were also measured. We found that the changes observed in the conformation of the BSA molecule were associated with modifications of its antioxidant properties. The latter were studied by the copper-mediated oxidation of human low density lipoproteins and the free radical-induced blood hemolysis test. Our data support the concept that oxidative-induced BSA modifications are important determinants in the antioxidant properties of BSA. Glycated BSA still behaved as an antioxidant but became pro-oxidant in the presence of copper, probably by generating oxygenated species. These data confirm the key role of metals ions in this process. Although these results warrant further in vivo investigations, we propose that, considering the poor glucose control found in diabetics as well as the key role of oxidative stress in vascular complications, glycation-mediated and free radical-induced impairment of the antioxidant properties of albumin might be important parameters in vascular complications encountered in diabetes.—Bourdon, E., Loreau, N., Blache, D. Glucose and free radicals impair the antioxidant properties of serum albumin.


Key Words: : oxidation • LDL oxidation • red blood cell hemolysis • atherosclerosis • diabetes


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
MANY EPIDEMIOLOGICAL STUDIES have established an inverse relationship between serum albumin level and mortality risk. In diseased populations as well as in the general population, it has been estimated that the odds of death increase by about 50% for each 2.5 g/l decrement in the initial albumin level (reviewed in ref 1 ). This association holds also for cardiovascular disease after adjustment for the usual risk factors (2 , 3 ). With normal concentrations lying between 35 to 50 g/l, the serum level of albumin is mainly related to its synthesis and catabolism, but also to its transcapillary escape. Variation in the albumin concentration may reflect variation in the nutritional state. In fact, only a small number of factors are known to result in variation in serum albumin. Besides analbuminemia, a rare congenital disease (4 , 5 ), the main pathological situation known to lower albumin concentration, is the nephrotic syndrome, which is the subject of most studies (6 , 7 ). In addition, it has been reported that serum albumin decreases with age and cigarette smoking (2) .

Among the variety of biological mechanisms that have been proposed to explain the beneficial effects of higher albumin concentrations, a direct protective effect of the albumin molecule has been suggested. There is now evidence for a significant antioxidant activity of serum albumin. In fact, this molecule may represent the major and predominant circulating antioxidant in plasma known to be exposed to continuous oxidative stress (8 , 9 ). Albumin may thus represent a quantitatively important component that plays a role in the efficient antioxidant defense organisms have developed to protect against oxidative attack (10) .

In addition, alteration of the structure of albumin may result in modifications of its biological properties. These modifications could occur in insulin-dependent diabetes mellitus, which is one of the pathological conditions associated with early occurrence of vascular complications, together with structural and functional alterations of albumin, which undergoes increased glycation (11) . The usual half-life of albumin is 20 days. The binding of glucose to albumin typically occurs in vivo and is known to involve the nonenzymatic covalent attachment of glucose to a lysine side chain. Approximately 6 to 10% of the albumin in normal human serum is modified by nonenzymatic glycosylation (12) . This proportion typically increases between two- to threefold in hyperglycemia (13) . Moreover, diabetic patients exhibit elevated levels of iron and copper ions that, in the presence of glycated proteins, have been shown in vitro to generate free radicals (14) . These highly reactive species are able to induce oxidative degradation of protein in vitro (15) .

Oxidant stress is increasingly thought to be a key element in atherogenesis. Atherosclerosis is a complex multifactorial disease caused by an excessive accumulation of lipids in the vascular wall. Lipids are essentially found in foam cells, which result from the transformation of smooth muscle cells and macrophages (16 , 17 ). By damaging lipids of low density lipoprotein (LDL),2 free radicals generate proatherogenic oxidized particles (18 , 19 ). These antioxidant-depleted, oxidized lipid-enriched lipoproteins accumulate polyunsaturated fatty acid breakdown substances that secondarily react with the apolipoprotein B of LDL. These modified LDL are no longer recognized by their classical LDL receptor (20) but by scavenger receptors that are not down-regulated by excess cholesterol (21 , 22 ). This oxidative stress hypothesis is also reinforced by data provided by various studies of the beneficial effects of lipid-soluble antioxidants 23-27) . Indeed, although a precise cause-and-effect relationship between the susceptibility of LDL to oxidation and the potential benefits of antioxidant therapy with respect to vascular lesion development and/or reduction has not yet been established, particularly in clinical trials, studies in animals and humans indicate that supplementation with antioxidants increases the resistance of LDL to oxidation.

In the present work, we first investigated whether in vitro glycation and oxidation of bovine serum albumin (BSA) might alter its structural parameters. Second, using copper-mediated LDL oxidation and free radical-initiated hemolysis, we examined whether these modifications might be associated with changes in the antioxidant properties of this protein.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
All chemicals were obtained from Sigma (St. Louis, Mo.). Typical commercial preparations of BSA are purified from pooled blood derived from nonhyperglycemic bovines and are therefore considered to be minimally glycated.

In vitro glycation of BSA
BSA was dissolved in phosphate-buffered saline (PBS), pH 7.4, to yield a stock solution of 40 mg/ml. This solution was subsequently diluted with glucose stock solutions made in PBS to form triplicate incubation mixtures of 10 mg/ml BSA with 0, 5, 25, 100, and 500 mmol/l glucose. After being sterilized by filtration (0.22 µm filters, Millipore), the solutions were incubated at 37°C for 60 days under argon gas in capped vials. Reversible and unbound glucose was removed from BSA by extensive dialysis against PBS, pH 7.4 and stored at 4°C in the dark prior to analysis for oxidative modification. As no variations in the extinction coefficient were observed between the different samples (CV<6%, n=15), the measurement of BSA concentration was performed by absorbance at 278 nm (12) .

Oxidative modification of BSA
Dialyzed samples of BSA (previously incubated with 0, 5, 25, 100, and 500 mmol/l glucose) were incubated with a water-soluble free radical generator, 2,2' azo-bis(2-aminodinopropane) HCl (AAPH, >95% pure, supplied by Lara-Spiral, Dijon, France). In a typical experiment, 2.5 mg/ml BSA was incubated for 1 h at 37°C with 12.5 mmol/l AAPH. Reactions were stopped by cooling and extensive dialysis at 4°C against PBS, pH 7.4. Thiol groups of native or modified BSA were measured according to the Ellman's assay (28) using 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB). Briefly, BSA samples (3.5 mg/ml) were mixed with 0.05 mol/l PBS pH 7.6 and incubated with 2.5 mmol/l DTNB for 15 min. The absorbance was measured at 410 nm. The free thiol concentration of samples was calculated with the help of a standard curve performed with various native BSA concentrations (0.8 to 4 mg/ml, corresponding to 19 to 96 nmol total thiols).

Fluorescence studies
As BSA contains two tryptophan residues (Trp213 and Trp134), we could evaluate the effects of glycation and free radical attack on its molecular conformation by assaying the fluorescence intensity of BSA solutions. Fluorescence measurements of BSA samples (0.01 mg/ml) were monitored using a spectrofluorometer (LS50B Perkin-Elmer) at excitation and emission wavelengths of 280 and 340 nm, respectively, as previously described (29) .

The production of fluorescent products or glycophore was monitored on samples with a concentration of 0.5 mg/ml BSA as previously described (30) at excitation and emission wavelengths of 350 and 425 nm, respectively.

Quenching of fluorescence
As acrylamide was previously shown not to alter the protein conformation (31) , it was thus used as a quenching agent in our experiments to examine the effects of glycation and oxidation on the fluorescence of Trp residues measured as above ({lambda}ex 280 and {lambda}em 340 nm). Acrylamide was added to the various BSA preparations in final concentrations of up to 0.32 mol/l. The results of triplicate assays are expressed as mean values of I0/I (Stern-Volmer constant), where I0 and I were the albumin fluorescences before and after addition of the quencher, respectively (31 , 32 ).

Boronate affinity chromatography
The formation of Amadori products was assessed by the percentage retention of modified materials on boronate affinity columns (11 , 33 ). Experiments were conducted as follows: 1 ml separating gel (60 µmol m-aminophenylboronic acid per ml, Sigma) was equilibrated with binding buffer (0.2 mol/l ammonium acetate, pH 8.8) and 1 ml of 1 mg/ml BSA modified samples was applied. Bound materials were eluted with 6 ml of elution buffer (0.15 mol/l NaCl, 0.01 mol/l MgCl2, 0.2 mol/l mannitol, pH 2.0). The separating gels were regenerated with 4 ml of 0.02 mol/l NaOH, 5 ml of 0.05 mol/l acetic acid, and 10 ml of distilled water.

LDL preparation and oxidation
LDL (1.019–1.055 g/ml) were isolated by sequential ultracentrifugation of pooled plasma from normolipidemic subjects (Beckman centrifuge). After dialysis against PBS, pH 7.4, LDL were assayed for protein content by the bicinchoninic acid method (34) and stored at 4°C under argon in the dark for no longer than 15 days.

Oxidation of LDL was conducted in a 500 µl sample volume using 100 µg/ml of LDL protein without or in the presence of the various BSA preparations (final concentration, 2 mg/ml). Accordingly, with the work of Schnitzer et al. (35) we confirmed that due to interferences at elevated BSA concentrations, the monitoring of the conjugated dienes for lipid oxidation usually measured at 234 nm (36) was improved at 245 nm. Consequently, oxidation of LDL was started by adding 40 µl of CuSO4 (40 µmol/l) and lipid oxidation was measured by spectrophotometry at 245 nm in a thermostated cuvette holder maintained at 37°C (Beckman DU 640).

The effects of the various BSA preparations were also studied on the Cu2+-induced production of thiobarbituric acid reactive substances (TBARS). After temperature equilibration (10 min) at 37°C, experiments were performed as above except that Cu-driven oxidations were stopped at 10 min by adding 10 µl of a solution containing 100 µmol/l BHT and 200 µmol/l EDTA in PBS. LDL TBARS are expressed in malondialdehyde equivalents as described (37 , 38 ). Agarose gel electrophoresis (0.5%) was performed to follow the LDL mobility with a Beckman's Paragon lipoprotein electrophoresis kit.

Free radical-induced hemolysis test
The antioxidant properties of the native and modified BSA preparations were examined using a test based on in vitro free radical-induced blood hemolysis 39-44) . After an overnight fast, blood samples were taken from rats using 10% (v/v) buffered sodium citrate as anticoagulant. Results were expressed as 50% of maximal hemolysis time (HT50 in min), which refers to the susceptibility of whole blood to free radicals. The measurement of HT50 was very reproducible: intra- and interassay coefficients of variation, 1.32% and 3.85%, respectively. In humans and animal models where oxidative stress has been well documented, HT50 was shown to be representative of the total defense against free radicals (40 , 42 , 43 ). Hemolysis was started by adding 52.4 mol/l AAPH and assayed by measuring the decay of the optical density at 450 nm (MRX Dynatech) of rat blood diluted to 1/50 in NaCl 0.15 mol/l without or in the presence of the various BSA samples (2 mg/ml final concentration).

Statistical analysis
Data are expressed as the means ± standard deviation (SD) from at least three experiments performed in triplicate. The main effects of glycation and oxidation or their interactions were evaluated using two-way analysis of variance (ANOVA) performed with Prism (GraphPad Software Inc., San Diego, Calif.). When the interactions were found to be statistically significant, the individual significances of glycation and oxidation main effects were not taken into consideration. After ANOVA, the significance of differences (P<0.05) among means was analyzed by multiple comparisons, using the Honestly Significant Difference test of Tukey or the Newman-Keuls' test. Univariate correlation coefficients were calculated according to Pearson's method.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
BSA modifications
Experiments were designed to determine whether long-term incubations in vitro with glucose might change the conformation of the BSA molecule. Due to its high sensitivity and reproducibility, the level of fluorescence of the two tryptophan residues has been chosen as an index of the conformational changes. Figure 1 shows that incubation of BSA at 37°C with various glucose concentrations for 60 days resulted in a progressive decrease in tryptophan fluorescence compared with native BSA (-42% loss with BSAG500). This reduction was associated with a parallel increase in the fluorescence attributed to the formation of the glycophore (Fig. 1) , which is significant at glucose concentrations as low as 5 mmol/l (P<0.001, BSAG5 vs. BSAnative).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Effect of glucose on tryptophan fluorescence and glycophore formation of BSA. Triplicate BSA samples (10 mg/ml) were thoroughly dialyzed after incubation with 0, 5, 25, 100, and 500 mmol/l glucose at 37°C for 60 days as described in Materials and Methods. Tryptophan fluorescence ({blacksquare}) was assessed using excitation and emission wavelengths of 280 and 340 nm, respectively. Glycophore formation ({bullet}) was measured at excitation and emission wavelengths of 350 and 425 nm, respectively. The significance of the results expressed as mean ±SD, n=3 was determined by comparison with control values using one-way ANOVA, followed by Dunnett's test. ***P < 0.001. Note that SD bars are sometimes smaller than symbols.

The results of preliminary dose-response studies as well as time course studies have shown that AAPH can be used to produce minimally oxidized BSA under strictly controlled conditions. Consequently, free radical-mediated oxidation of glucose-modified BSA was also studied by exposure to the products of thermo-decomposition of AAPH. When compared with native BSA (Fig. 2 ), data indicate a drastic decrease in tryptophan fluorescence, which remained invariable (-70.1%, CV=2.8, n=4) whatever the glycation degree of BSA. No difference was observed in the glycophore fluorescence between native or glycated BSA with the same sample after AAPH-mediated oxidation (data not shown). This means that important changes in tryptophan fluorescence associated with glycated and oxidized BSA were not due to protein destruction. This was also confirmed by results of analyses by polyacrylamide gel electrophoresis (data not shown).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. Effect of free radicals on tryptophan fluorescence of native and glucose-modified BSA. BSA samples (2.5 mg/ml), prepared as in Fig. 1 , were incubated with AAPH-generated free radicals (12.5 mmol/l) at 37°C for 1 h. Reactions were stopped by cooling and extensive dialysis at 4°C against PBS, pH 7.4. Tryptophan fluorescence was assessed as in Fig. 1 . Values are mean ±SD of at least three preparations. Statistical significance was assessed using ANOVA, followed by Tukey's test; oxidation effect (unoxidized vs. oxidized), +++P < 0.001; glycation effect (vs. 0 glucose), P < 0.05, °°°P < 0.001.

As albumin is thought to represent the quantitatively most important source of thiols in plasma, we examined whether these groups were altered by our incubation conditions. We found that oxidation of BSA by free radicals strongly decreased the thiols (by more than 77%, P <0.01) whereas glucose-induced modifications did not appear to significantly affect them (Fig. 3 ). Results obtained by using two-way ANOVA indicate that interactions between glycation and oxidation were not significant and the oxidation process accounts for 77% of the total variance (P <0.0001). These effects were opposed by adding an antioxidant such as ascorbic acid (Fig. 3) .



View larger version (24K):
[in this window]
[in a new window]
 
Figure 3. Effects of glucose and free radicals on thiol groups of BSA. BSA samples were treated with various concentrations of glucose and oxidized by AAPH as in Fig. 2 without or with 200 µmol/l vitamin C. Thiol groups of native or modified BSA were measured according to the Ellman's assay (28). Values are mean ±SD of three preparations. Statistical significance was assessed using ANOVA, followed by Tukey's test; ++P < 0.01, ++P < 0.001.

Glucose-induced modifications were assessed by the formation of Amadori products using boronate column chromatography. An elevation of the retained material boronate column was observed when BSA was incubated with increased concentrations of glucose (+362% for BSAG500 vs. BSAnative). The same results in boronate binding were observed whether glycated or native BSA was oxidized or not by AAPH (data not shown). Boronate affinity chromatography studies showed that, as already observed by Coussons et al. (45) , approximately 20% of nonglycated starting material (native BSA) was retained on boronate affinity columns (Fig. 4 ). This may be due to nonspecific interactions with the boronate gel.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 4. The formation of Amadori products in glucose-modified BSA. BSA samples, prepared as in Fig. 1 , were applied to boronate column chromatography as described in Materials and Methods. Values are mean ±SD of three or four preparations and expressed as the ratio of the retained material to total BSA. Statistical significance was assessed using ANOVA, followed by Newman-Keuls' test; °°°P < 0.001.

As illustrated in Fig. 5 , the fluorescence of the different modified BSA preparations could be quenched using increasing concentrations of acrylamide (31 , 32 ). the quasi-linearity of the Stern-Volmer plots indicated that the quenching process followed a collision-type mechanism. The calculated Stern-Volmer constants (Table 1 ), representing the slopes of the plots and expressing tryptophan accessibility to the quencher, were different for BSAnative, BSAG100, and oxidized BSA. These results indicate that the environment of the tryptophan residues is different with regard to the effect of glycation and/or oxidation.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 5. Stern-Volmer plots of acrylamide quenching of the tryptophan fluorescence of glucose and free radical-modified BSA preparations. Tryptophan fluorescence was assessed using excitation and emission wavelengths of 280 and 340 nm, respectively. Native ({blacksquare}) or oxidized ({blacktriangledown}) BSA; BSA incubated with 100 mmol/l glucose ({blacktriangleup}) and oxidized ({blacklozenge}) as described in Materials and Methods. I and I0 are the fluorescence intensities with and without quencher, respectively. Note that SD bars are not represented for reasons of clarity.


View this table:
[in this window]
[in a new window]
 
Table 1. Stern-Volmer constants of the quenching of the fluorescence of native and modified BSA preparationsa

Antioxidant effect of modified BSA
To examine whether the glycation of BSA or its oxidation status had any effect on its antioxidant properties, incubations were performed in two different systems that involved different mechanisms: the copper-induced oxidation of LDL and the free radical-mediated hemolysis.

Copper-mediated LDL oxidation
The effects of the native and modified BSA on Cu-induced oxidation kinetics of LDL are illustrated in Fig. 6 , which represents monitoring of the conjugated dienes adapted for BSA at 245 nm (35) . The usual three phases of the oxidation kinetics were obtained (46) . First, there is a lag phase when endogenous antioxidants are progressively consumed. Next, there is the propagation phase with a rapid increase in absorbance. The last phase is the decomposition of hydroperoxides during which no further increase in absorbance occurs. In the presence of native BSA, a strong increase in the lag time was observed indicating a marked antioxidant activity of native BSA. The shift of the progress curves toward longer times was correlated with increasing concentrations of BSA (not shown). Oxidation kinetics of LDL incubated in the presence of BSA with increasing concentrations of glucose showed that this protective effect was progressively lost. In addition, higher glucose concentrations (100 and 500 mmol/l) resulted in pro-oxidant effects as shown by shifts of the progress curves toward shorter times by comparison with control conditions. When results are expressed as the rate vs. time by the first derivative dA/dt, a maximum was obtained by computer analysis that corresponds to the time necessary to obtain 50% oxidation (T1/2) (36) . A value of 25.0 ±1.0 min was calculated for native BSA (Fig. 7 ), which represents an increase of +67% in comparison with LDL alone (15.1±0.4 min). These peak times decreased to 18.5 ±0.7, 16.0 ±0.4, 9.7 ±0.3, and 6.6 ±0.3 min for BSA modified by 5, 25, 100, and 500 mmol/l glucose, respectively.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 6. Effects of glucose and free radical-modified BSA on the copper-induced LDL oxidation. Oxidation of LDL (100 µg/ml) was started by adding 40 µmol/l CuSO4 and monitored by the absorbance of the conjugated dienes (245 nm) in the absence (control, dashed line) or presence of the various BSA preparations (2 mg/ml). Note that SD bars are sometimes smaller than symbols.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 7. Effects of free radicals of the glucose-modified BSA preparations on the Cu-mediated oxidation of LDL. Oxidation was performed as in Fig. 6 . Histograms show the half maximum oxidation time in min (T1/2) expressed as mean ±SEM of three or four independent experiments. Significance of the results using one-way ANOVA, followed by Newman-Keuls' test; ***P <0.001 vs. Control; °°°P < 0.001 vs. BSAnative; comparison of unoxidized vs. oxidized: ++P < 0.01, +++P < 0.001.

We also studied the effects of in vitro oxidation and glycation on the antioxidant properties of BSA; the results, expressed as T1/2 of the Cu-initiated oxidation of LDL, are illustrated in Fig. 7 . Oxidation of native BSA resulted in complete loss of its antioxidant capacity since a T1/2 similar to that obtained in the absence of BSA was found (12.6±1.6 and 15.1±0.4 min, respectively). Also, oxidized BSAG further decreased T1/2 for the LDL oxidation as compared with BSAG alone. This was particularly evident for BSA glycated by physiological (5 mmol/l) and diabetic glucose (25 mmol/l) concentrations, where 31.5% and 18.7% significant decreases were found (oxidized BSAG vs. BSAG, respectively). As for BSA preincubated in the presence of high glucose concentrations (500 mmol/l) alone, oxidation of BSAG500 also resulted in pro-oxidant effects, as evidenced by shorter T1/2 in comparison with control conditions (5.4±0.6 vs. 15.1±0.4 min, P<0.001, respectively).

Copper-mediated LDL oxidation was also measured as TBARS and the results of the changes of the antioxidant properties of native and modified BSA are summarized in Table 2 . To optimize the differences between the samples, incubations were stopped at 10 min according to the initial kinetic data such as those illustrated in Fig. 6 . In the presence of BSAnative, the TBARS produced in oxidized LDL were significantly reduced by 33%. Table 2 also shows that the more glycated the BSA, the more TBARS were produced. For BSA incubated in 500 mmol/l glucose, the change was even more drastic since results indicating a pro-oxidant effect (by 145%) were in line with the data reported in Figs. 6 and 7 . Furthermore, the antioxidant activity of native BSA was no longer observed in the presence of the various AAPH-oxidized BSA preparations (Table 2) . Increased TBARS were generated significantly during Cu-mediated LDL oxidation when incubated with BSAG compared to BSAnative.


View this table:
[in this window]
[in a new window]
 
Table 2. Influence of native and modified BSA on copper-induced oxidation of LDLa

As oxidative modifications of the apo B moiety of LDL is known to produce an increase in the electrophoretic mobility, LDL oxidation was also monitored by agarose gel electrophoresis. As expected, the LDL mobility relative to appropriate controls was significantly reduced for incubations conducted in the presence of BSAnative. When LDL were Cu-oxidized in the presence of BSA glycated with increasing concentrations of glucose, their mobility became more and more augmented. Thus, with BSAG100 and BSAG500, oxidized LDL migrated faster than in the absence of BSA (control), indicating the pro-oxidant effect of BSA glycated by preincubation with high concentrations of glucose. As already observed for dienes and TBARS, the LDL relative electrophoretic mobility was markedly more elevated in the presence of oxidized BSAG than in the presence of BSAG.

Free radical-induced hemolysis
The antioxidant properties of BSAnative, BSAG, and oxidized BSAG were also investigated by means of our hemolysis test, which measures the susceptibility of whole blood to free radicals. Typical hemolysis curves are illustrated in Fig. 8A . As expected, the free radical scavenging property of native BSA was evidenced by the significant increase in the presence of native BSA (+41%) as compared with controls (185.5±1.5 and 131.4±1.2 min, P<0.001, respectively). The antioxidant activity of free radical-treated BSA was strongly impaired (Fig. 8A ; 176.6±1.9 min, P ±0.001 vs. native BSA). In contrast, glycation tended to increase the antioxidant activity of BSA either alone or with oxidation (Fig. 8B ). However, a comparison with the corresponding unoxidized BSA preparation indicated that oxidation consistently induced a significant decrease in the antioxidant effect of modified BSA.



View larger version (43K):
[in this window]
[in a new window]
 
Figure 8. Effects of oxidized and glucose-modified BSA preparations of the free radical-induced blood hemolysis test. Blood was prepared as described in Materials and Methods and incubated with free radicals generated from 52.4 mmol/l AAPH at 37°C. Hemolysis was monitored by spectrophotometry at 450 nm and data were curve-fitted by computer analysis. A) Curves illustrating the antioxidant effect of native ({blacktriangleup}) and oxidized BSA ({bullet}) were compared with controls ({blacksquare}). Results were expressed as 50% of maximal hemolysis time (HT50 in min). B) Histograms showing the effects of unoxidized and oxidized native and glucose-modified BSA on the free radical-induced blood hemolysis. Results HT50 were expressed as percent of controls (without BSA=100%). Significance of the results as mean ±SD of three independent experiments using one-way ANOVA; ***P < 0.001 vs. Control; °°°P <0.001 vs. BSAnative; comparison of unoxidized vs. oxidized: +P < 0.05, +++ P < 0.001.

Correlations
Univariate correlations were calculated for the parameters affected by glycation-modified BSA (Table 3 ). The glucose concentration was marginally correlated with the binding to boronate chromatography, negatively correlated with the fluorescence of the tryptophans (P=0.011), and positively correlated with glycophore appearance (P=0.001), the production of TBARS, and the increase in the relative electrophoretic mobility of copper-oxidized LDL (P=0.013 and 0.017, respectively). The decrease in tryptophan fluorescence correlated negatively with boronate binding and positively with the appearance of the glycophore and with parameters of the LDL oxidation. The latter were positively related to the level of the glycophore.


View this table:
[in this window]
[in a new window]
 
Table 3. Univariate coefficients of variation and significance of various parameters after glycation of BSAa


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Based on the concept that a direct protective effect of albumin could be suspected from potential associations between its plasma concentration and mortality, the present work investigated the in vitro alterations of some properties of BSA by parameters encountered in pathophysiological conditions. We demonstrated that glycation and oxidation of BSA in vitro were associated with structural changes in this molecule. Using various experimental systems, we found that these modifications resulted in a drastic loss of the antioxidant properties exhibited by native BSA.

Several lines of evidence strongly suggest that a reduced serum albumin concentration, although within the normal range, is associated with mortality risk. From studies performed with healthy subjects and patients, it has been reported that the estimated increase in the odds of death ranges from 24% to 56% for each 2.5 g/l decrement in serum albumin concentration (1) . The association may predict overall and cause specific mortality, including cardiovascular mortality (2) . The serum albumin level thus appears to be an independent predictor of mortality risk. A direct protective effect of the albumin molecule is suggested by the persistence of the association after adjustment for other known risk factors, particularly for cardiovascular diseases. This idea may also be supported by the large variety of biological properties of albumin.

In the present work, we focused on the antioxidant activity of albumin because oxidative stress is thought to play a significant role in the pathogenesis of many diseases, including atherosclerosis 47-49) . There is now ample evidence suggesting that albumin, as the main circulating protein, is a quantitatively important antioxidant in the blood and extracellular fluids (50 , 51 ). Our present data are in full agreement with this concept, since by using different approaches we consistently found that BSA markedly delayed the copper-initiated oxidation of LDL as monitored by the appearance of conjugated dienes, changes in the electrophoretic mobility, and formation of end products of fatty acid oxidation such as TBARS. Second, BSA offered a significant protection against free radical-mediated blood hemolysis. These antioxidant effects were found to be concentration dependent, which is consistent with the idea of a beneficial effect of high albumin levels in humans.

However, the main purpose of this work was to extend the above-mentioned idea by proposing that besides its concentration, the integrity of the albumin molecule might be a key determinant of its activity. We found that when BSA was preincubated in the presence of various glucose concentrations, it progressively lost its antioxidant properties with regard to the propensity of LDL to oxidize. We present data consistent with the idea that under our conditions only minor modifications of the BSA molecule and no large damage occurred after incubation with glucose and free radicals. These changes have been demonstrated by a combination of fluorometry, boronate binding, and thiol group assay. First, a progressive glycation of BSA has been evidenced by the progressive increase in boronate binding of BSA incubated in vitro with increasing glucose concentrations. This has been attributed to the attachment of glucose to the amino group of the exposed lysine side chain, resulting at first in the formation of reversible Schiff's bases and Amadori products, which then irreversibly rearrange into the so-called advanced glycated end products (11 , 52 ). We next found that the concentration of these fluorescent glycophores markedly increased in BSA after incubation with glucose under our conditions (Fig. 1) . Finally, our finding that the glycophore formation was concomitant with the decrease in the tryptophan fluorescence confirms the data of Coussons et al. (45) . In keeping with previous work conducted with human albumin (12) , the decrease in the fluorescence of the tryptophanyl residues has been attributed to glycation-dependent conformational changes within the protein that affected the local environment of the tryptophan. It is well known that, although human serum albumin contains only one tryptophan compared to two in BSA, these proteins have a similar structure and conformation (53) . From studies of fluorescence behavior in the presence of surfactants, it has been proposed that Trp-214, the tryptophan residue of HSA, behaves similarly to the Trp-213 of BSA. Both tryptophans have lysine in their close vicinity that can bind glucose. Fluorescence quenching assessed the resulting conformational changes. We used acrylamide as a quenching agent to probe the change in the degree of exposure of tryptophan in modified BSA. As glycated and oxidized BSA had different Stern-Volmer constants, these data indicate that modified BSA preparations are in different conformational status. A glucose-induced decrease (by 23%) in the constant probably indicated that glycation led to a reduced accessibility of the probe to the hydrophobic fold where Trp-213 is located. Oxidation of native BSA resulted in a more drastic effect, since a 65% decrease was observed. However, the oxidation process did not appear to induce further changes in the conformation of the protein, as similar constants were found for the glycated BSA and the free radical-treated glycated BSA (Table 1) . However, as evidenced by polyacrylamide gel electrophoresis (data not shown), all these changes did not result in large damage to the protein such as fragmentation or aggregation.

The precise antioxidant mechanism of BSA is not known. However, from the present data dealing with hemolysis and as suggested by several studies conducted with LDL, BSA can work as a radical trapping and/or a metal sequestering agent (54 , 55 ). Glycation and oxidation may affect these processes differently. Although various amino acids such as His, Trp, and Lys are thought to play important roles, the peculiar effects of thiol-containing amino acids have been the subject of specific studies. In particular, the thiol group of Cys residues may play a role in free radical damage to proteins, as it is known that the formation of disulfide bonds occurs in protein aggregation and results in the loss of enzymatic activity (56 , 57 ). This is in line with our observation that free radical-treated BSA lost more than 77% thiols. As suggested by Davies et al. (56) when using EPR spin trapping with BSA, thiols may work either as a radical sink, thus protecting the protein from entire denaturation, or as agents transferring the damage to other sites such as the peptide backbone. This may explain why we found that in some instances, BSA not only lost its antioxidant effect but also became pro-oxidant (Fig. 6) . This markedly occurred with glycated BSA after incubations in glucose concentrations as low as 5 mmol/l and submitted to metal-catalyzed oxidation. This is in keeping with reports indicating that glycated proteins can generate free radicals in the presence of copper ions (14 , 58 ). Two mechanisms, both metal-catalyzed oxidations, by which glucose may induce oxidative structural changes in protein have been proposed. The first results from `glucose auto-oxidation', which generates oxidants and protein-reactive aldehydes by glucose in solution. The second, named `glycoxydation', generates similar products by glucose once attached to the protein. Although the glycophore formation was measured in our study, a more detailed analysis of the carbohydrate chemistry in modified BSA should be conducted in future studies. It would help to better characterize and compare the different effects observed between glycation alone and glycation plus oxidation. However, from our data obtained in AAPH-induced hemolysis, we provided new evidence to explain the mechanism of the antioxidant effects of native BSA. The increase in the hemolysis time observed with native BSA was significantly reduced with the glycated and oxidized BSA. Conversely, a certain antioxidant effect was still preserved with only glycated BSA. Although specific binding studies should be performed to precisely characterize the glucose-induced change in copper binding of BSA (35) , our data confirm the key role of metals in the pro-oxidant process. In our experiments, the effect of glycation could be to increase the pro-oxidant properties of BSA rather than decrease its antioxidant activity. These conclusions as well as the conformational changes of the native and modified BSA are summarized in the schematic representation of Fig. 9 .



View larger version (22K):
[in this window]
[in a new window]
 
Figure 9. Proposed schematic models of the glycation- and oxidation-induced changes of the structure and the properties of the BSA molecule. A) Native BSA (or BSAG0) is in its normal globular conformation and thus presents an important intrinsic fluorescence of its two tryptophanyl residues (Trp, zigzagged arrows). The antioxidant activity of BSA is expressed both by metal ion (Cu) binding capacity and a free radical trapping property due to the occurrence of thiol groups in their reduced form (SH). Lysine residues (Lys) are in their free forms. B) The configuration of the weakly glycated BSA (BSAG25) has changed as assessed by a reduced tryptophan fluorescence and a change in the accessibility of the quencher (acrylamide) to BSA. Some lysine residues are glycated (Glc). C) Highly glycated BSA (BSAG100) presents a strongly diminished tryptophan fluorescence and a markedly modified conformation. Cu ions cannot bind to the protein and are more prone to react with the numerous glycated lysine residues leading to new free radicals (FR). The latter can oxidize thiols into disulfure linkages or thiyl radicals (S-S or S, respectively), which can also promote oxidation. The conformation of the free radical-treated BSAnative (D) is strongly altered as assessed by a marked decrease in tryptophan fluorescence. The metal ion binding capacity is impaired and the number of thiol groups in reduced form is decreased. The resulting effects are 1) a decrease in the total antioxidant activity of BSA and 2) free copper ions may therefore be available to induce oxidant stress. When glycated BSA is also treated with free radicals as in panel E, the decrease in tryptophan fluorescence is in favor of a drastic conformational change. The free copper ions may react with the glycated lysine residues and promote the generation of free radicals. Since the thiols are already in an oxidized form, in the presence of metal ions and advanced glycated end-products, oxygenated reactive species production may be enhanced.

In conclusion, the present work confirms and extends the idea that serum albumin is an important protein that presents direct protective effects. These effects are based on a variety of biological mechanisms. In this report, we point to the antioxidative properties of albumin. Using fluorescence measurements, we found that structural changes occurred when albumin was incubated in increasing glucose concentrations, under oxidizing conditions, or both. These structural changes resulted in impairments of the biological activities of albumin as assessed in vitro for its antioxidative properties. Our data bring further support to the proposal that, in addition to its plasma concentration, the quality of the albumin molecule may be related to its biological properties. In particular, advanced glycated end-products accumulate at an accelerated rate in diabetes. A receptor system for these products has been described in various cells, including monocytes and vascular cells, that can trigger the secretion of reactive oxygen species and cytokines. Recently, glycated albumin has been reported to induce the expression of tissue factor in monocytes with the involvement of oxidative stress. This further confirms the role of modified albumin as a key element in the onset of hypercoagulability complications. As beneficial effects of high albumin concentrations have been reported in platelet activity, work is in progress in our laboratory to document the modulation of platelet function by modified forms of albumin. Albumin represents the quantitatively most important source of thiol in plasma, and this circulating store may be altered in situations where antioxidants become limiting resulting in changes in the redox status. For instance, compounds such as homocysteine, which accumulates in folate deficiency, may have pro-oxidant effects (59) and may combine with the thiols of albumin. Cells can generally remove oxidized proteins by proteolysis. However, certain oxidized proteins are poorly handled by cells (57 , 60 ), and this may contribute to the observed accumulation and damaging actions of oxidized proteins during aging and pathologies such as diabetes, atherosclerosis, and neurodegenerative diseases.


   ACKNOWLEDGMENTS
 
This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the Conseil Régional de Bourgogne, and the Université de Bourgogne. The support of ARCOL is also greatly appreciated. The authors would like to thank Dr. S. Lussier-Cacan (Canada) for kindly editing the manuscript, Freddy Boutron, MSc, for skillful help, and Xavier David for technical assistance. E.B. is supported by a fellowship from the Ministère de l'Education Nationale, de l'Enseignement Supérieure et de la Recherche.


   FOOTNOTES
 
1 Correspondence: INSERM U498, Biochimie des Lipoprotéines et Interactions Vasculaires, Université de Bourgogne, 7, Bd Jeanne d'Arc, 21033 Dijon, France. E-mail : dblache{at}u-bourgogne.fr

2 Abbreviations: AAPH, 2,2' azobis 2-amidinopropane HCl; AGE, advanced glycation end products; ANOVA, analysis of variance; BSA, bovine serum albumin; BSAG0, native BSA or 0 mmol/l glucose-incubated BSA; BSAGX, BSA glycated by incubation with x mmol/l of glucose; DTNB, 5,5'-dithiobis(2-nitrobenzoic acid); HT50; 50% hemolysis time; LDL, low density lipoproteins; PBS, phosphate-buffered saline;TBARS, thiobarbituric acid reactive substances.

Received for publication July 3, 1998. Revision received October 14, 1998.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Goldwasser P., Feldman J.. Association of serum albumin and mortality risk. J. Clin. Epidemiol. 1997;50:693-703.[Medline]
  2. Phillips A., Shaper A. G., Whincup P. H.. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet 1989;16:1434-1436.
  3. Luoma J., Nàyhà S., Sikkilà K., Hassi J.. High serum alpha-tocopherol, albumin, selenium and cholesterol, and mortality from coronary heart disease in northern Finland. J. Int. Med. 1995;237:49-54.[Medline]
  4. Montgomery D. A. D., Neill D. W., Dowdle E. B. D.. Idiopathic hypoalbuminemia. Clin. Sci. 1962;22:141-154.[Medline]
  5. Dammaco F., Miglietta A., D'Addabbo A., Fratello A., Moschetta R., Bonomo L.. Analbuminemiareport of a case and review of the literature. Vox Sang 1980;39:153-161.[Medline]
  6. Wheeler D. C., Bernard D. B.. Lipid abnormalities in the nephrotic syndromecauses, consequences, and treatment. Am. J. Kidney Dis. 1994;23:331-346.[Medline]
  7. Harris R. C., Ismail N.. Extrarenal complications of the nephrotic syndrome. Am. J. Kidney Dis. 1994;23:477-497.[Medline]
  8. Soriani M., Pietraforte D., Minetti M.. Antioxidant potential of anaerobic human plasmarole of serum albumin and thiols as scavengers of carbon radicals. Arch. Biochem. Biophys. 1994;312:180-188.[Medline]
  9. Cha M. K., Kim I. H.. Glutathione-linked thiol peroxidase activity of human serum albumina possible antioxidant role of serum albumin in blood plasma. Biochem. Biophys. Res. Commun. 1996;222:619-625.[Medline]
  10. Halliwell B.. Antioxidants in human health and disease. Annu. Rev. Nutr. 1996;16:33-50.[Medline]
  11. Wolff S. P., Jiang Z. Y., Hunt J. V.. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad. Biol. Med. 1991;10:339-352.[Medline]
  12. Shaklai N., Garlick R. L., Bunn H. F.. Non enzymic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 1984;259:3812-3817.[Abstract/Free Full Text]
  13. Woodside J. V., Yarnell J. W. G., McMaster D., Young I. S., Harmon D. L., McCrum E. E., Patterson C. C., Gey K. F., Whitehead A. S., Evans A.. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemiaa double-blind, randomized, factorial-design, controlled trial. Am. J. Clin. Nutr. 1998;67:858-866.[Abstract]
  14. Dean R. T., Hunt J. V., Grant A. J., Yamamoto Y., Niki E.. Free radical damage to proteinsthe influence of the relative localization of radical generation, antioxidants, and target proteins. Free Rad. Biol. Med. 1991;11:161-168.[Medline]
  15. Pacifici R. E., Davies K. J. A.. Protein, lipid and DNA repair systems in oxidative stressthe free-radical theory of aging revisited. Gerontology 1991;37:166-180.[Medline]
  16. Ross R.. The pathogenesis of atherosclerosisa perspective for the 1990s. Nature (London) 1993;362:801-809.[Medline]
  17. Berliner J. A., Heinecke J. W.. The role of oxidized lipoproteins in atherogenesis. Free Rad. Biol. Med. 1996;20:707-727.[Medline]
  18. Esterbauer H., Gebicki J., Puhl H., Jürgens G.. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 1992;13:341-390.[Medline]
  19. Aviram M.. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.[Medline]
  20. Goldstein J. L., Brown M. L.. The low density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 1977;46:897-930.[Medline]
  21. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S.. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. J. Biol. Chem. 1979;76:333-337.
  22. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L.. Beyond cholesterolModifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989;320:915-924.[Medline]
  23. Björkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P.. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arteriosclerosis 1991;11:15-22.[Abstract/Free Full Text]
  24. Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D.. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 1991;84:1086-1095.
  25. Reaven P. D., Parthasarathy S., Beltz W. F., Witztum J. L.. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans. Arterioscler. Thromb. 1992;12:318-324.[Abstract/Free Full Text]
  26. Nagano Y., Nakamura T., Matsuzawa Y., Cho M., Ueda Y., Kita T.. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit—long-term antiatherogenic effect and effects on established plaques. Atherosclerosis 1992;92:131-140.[Medline]
  27. Stampfer M. J., Rimm E. B.. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am. J. Clin. Nutr. 1995;62:1365S-1369S.[Abstract/Free Full Text]
  28. Ellman G. L.. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82:70-77.[Medline]
  29. Mooradian A. D., Lung C. C., Pinnas J. L.. Glycosylation enhances malondialdehyde binding to proteins. Free Rad. Biol. Med. 1996;21:699-701.[Medline]
  30. Ogino T., Okada S.. Oxidative damage of bovine serum albumin and other enzyme proteins by iron-chelate complexes. Biochim. Biophys. Acta 1995;1245:359-365.[Medline]
  31. Eftink M. R., Ghiron C. A.. Exposure of tryptophanyl residues and protein dynamics. Biochemistry 1977;16:5546-5551.[Medline]
  32. Faure P., Lafond J.-L., Coudray C., Rossini E., Halimi S., Favier A., Blache D.. Zinc prevents the structural and functional properties of free radical treated-insulin. Biochim. Biophys. Acta 1994;1209:260-264.[Medline]
  33. Vlassara H., Brownlee M., Cerami A.. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc. Natl. Acad. Sci. USA 1981;78:5190-5192.[Abstract/Free Full Text]
  34. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C.. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985;150:76-85.[Medline]
  35. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Lichtenberg D.. The effect of albumin on copper-induced LDL oxidation. Biochim. Biophys. Acta Lipids Lipid Metab. 1997;1344:300-311.[Medline]
  36. Blache D., Rodriguez C., Davignon J.. Pro-oxidant effects of 7-hydroperoxycholest-5-en-3ß-ol on the copper-initiated oxidation of low density lipoprotein. FEBS Lett 1995;357:135-139.[Medline]
  37. Quintanilha A. T., Paker L.. Membrane effects of vitamin E deficiencybioenergetic and surface charge density studies of skeletal muscle and liver mitochondria. Ann. N.Y. Acad. Sci. USA 1982;393:31-45.
  38. Blache D.. Involvement of hydrogen and lipid peroxides in the acute tobacco smoking-induced platelet hyperactivity. Am. J. Physiol. 1995;268:H679-H685.[Abstract/Free Full Text]
  39. Prost, M. (1992) Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive agents. U.S. Patent 5,135,850, Aug. 4.
  40. Blache, D., and Prost, M. (1992) Free radical attack: biological test for human resistance capability. Proceedings of the IX College Park Colloquium on Chemical Evolution: A Lunar-Based Chemical Analysis Laboratory (LBCAL) (Ponnamperuma, C., and Gehrke, C. W., eds) pp. 82–98, NASA, Washington, D.C..
  41. Durand P., Blache D.. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats. Atherosclerosis 1996;121:205-216.[Medline]
  42. Durand P., Prost M., Blache D.. Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity. Arterioscler. Thomb. Vasc. Biol. 1997;17:1939-1946.[Abstract/Free Full Text]
  43. Girodon F., Blache D., Monget A. L., Lombart M., Brunet-Lecompte P., Arnaud J., Richard M. J., Galan P.. Effect of two year supplementation with low dose antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and on antioxidant defense parameters. J. Am. Col. Nutr. 1997;16:357-365.[Abstract]
  44. Blache D., Durand P., Girodon F., Gesquière L., Loreau N.. Determination of sterols, oxysterols and fatty acids of phospholipids in cells and lipoproteinsa one sample method. J. Am. Oil Chem. Soc. 1998;75:107-113.
  45. Coussons P. J., Jacoby J., McKay A., Kelly S. M., Price N. C., Hunt J. V.. Glucose modification of human serum albumina structural study. Free Rad. Biol. Med. 1997;22:1217-1227.[Medline]
  46. Esterbauer H., Striegl G., Puhl H., Rotheneder M.. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 1988;6:67-75.
  47. Kehrer J. P.. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 1993;23:21-48.[Medline]
  48. Ames B. N., Shigenaga M. K., Hagen T. M.. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993;90:7915-7922.[Abstract/Free Full Text]
  49. Halliwell B.. Oxidative stress, nutrition and healthExperimental strategies for optimization of nutritional antioxidant intake in humans. Free Rad. Res. 1996;25:57-74.[Medline]
  50. Wayner D. D. M., Burton G. W., Ingold K. U., Locke S. J.. Quantitative measurement of total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett 1985;187:33-37.[Medline]
  51. Halliwell B., Gutteridge J. M. C., Cross C. E.. Free radicals, antioxidants, and human diseaseWhere are we now. J. Lab. Clin. Med. 1992;119:598-620.[Medline]
  52. Brownlee M.. The pathological implications of protein glycation. Clin. Invest. Med. 1995;18:275-281.[Medline]
  53. Moriyama Y., Ohta D., Hachiya K., Mitsui Y., Takeda K.. Fluorescence behavior of tryptophan residues of bovine and human serum albumins in ionic surfactant solutionsa comparative study of the two and one tryptophan(s) of bovine and human albumins. J. Protein Chem. 1996;15:265-272.[Medline]
  54. Thomas C. E.. The influence of medium components on Cu2+-dependent oxidation of low-density lipoproteins and its sensitivity to superoxide dismutase. Biochim. Biophys. Acta 1992;1128:50-57.[Medline]
  55. Zawadzki Z., Milne R. W., Marcel Y. L.. Cu2+-mediated oxidation of dialyzed plasmaeffects on low and high density lipoproteins and cholesteryl ester transfer protein. J. Lipid Res. 1991;32:243-250.[Abstract]
  56. Davies M. J., Gilbert B. C., Haywood R. M.. Radical-induced damage to bovine serum albuminrole of the cysteine residue. Free Rad. Res. Commun. 1993;18:353-367.[Medline]
  57. Dean R. T., Fu S. L., Stocker R., Davies M. J.. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 1997;324:1-18.
  58. Hunt J. V., Bottoms M. A., Clare K., Skamarauskas J. T., Mitchinson M. J.. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulationPossible implications for diabetic atherosclerosis. Biochem. J. 1994;300:243-249.
  59. Durand P., Lussier-Cacan S., Blache D.. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis and macrophage-derived tissue factor activity in rats. FASEB J 1997;11:1157-1168.[Abstract]
  60. Grant A. J., Jessup W., Dean R. T.. Accelerated endocytosis and incomplete catabolism of radical-damaged protein. Biochim. Biophys. Acta 1992;1134:203-209.[Medline]



This article has been cited by other articles:


Home page
J BiochemHome page
M. R. Khazaei, M. Habibi-Rezaei, F. Karimzadeh, A. A. Moosavi-Movahedi, A. A. Sarrafnejhad, F. Sabouni, and M. Bakhti
Microglial Cell Death Induced by Glycated Bovine Serum Albumin: Nitric Oxide Involvement
J. Biochem., August 1, 2008; 144(2): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Faure, R. Tamisier, J-P. Baguet, A. Favier, S. Halimi, P. Levy, and J-L. Pepin
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome
Eur. Respir. J., May 1, 2008; 31(5): 1046 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Shankar, R. Klein, B. E. K. Klein, and S. E. Moss
Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes
Am. J. Epidemiol., August 15, 2007; 166(4): 393 - 402.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K Nagai, T Betsuyaku, T Kondo, Y Nasuhara, and M Nishimura
Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid
Thorax, June 1, 2006; 61(6): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Arai, B. S. Berlett, P. B. Chock, and E. R. Stadtman
Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein
PNAS, July 26, 2005; 102(30): 10472 - 10477.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. J.S. Cooper, Y.-K. Chan, A. M. Dissanayake, F. E. Leahy, G. F. Keogh, C. M. Frampton, G. D. Gamble, D. H. Brunton, J. R. Baker, and S. D. Poppitt
Demonstration of a Hyperglycemia-Driven Pathogenic Abnormality of Copper Homeostasis in Diabetes and Its Reversibility by Selective Chelation: Quantitative Comparisons Between the Biology of Copper and Eight Other Nutritionally Essential Elements in Normal and Diabetic Individuals
Diabetes, May 1, 2005; 54(5): 1468 - 1476.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Holvoet, S. B. Kritchevsky, R. P. Tracy, A. Mertens, S. M. Rubin, J. Butler, B. Goodpaster, and T. B. Harris
The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort
Diabetes, April 1, 2004; 53(4): 1068 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W.-J. Zhang and B. Frei
Albumin selectively inhibits TNF{alpha}-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells
Cardiovasc Res, September 1, 2002; 55(4): 820 - 829.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page